Last reviewed · How we verify
NCT05000424
Clary Sage Essential Oil & Pregnancy
NA trial testing Clary Sage Massage Oil in Quality of Life in 50 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Nutraceuticals Research Institute |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 1 November 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Clary Sage Massage Oil
- Inert Massage Oil
Conditions studied
- Quality of Life — all drugs for Quality of Life →
- Pregnancy Related — all drugs for Pregnancy Related →
Sponsor
Nutraceuticals Research Institute
Who can join
Adults 20 to 39, female only, with Quality of Life or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the potential for clary sage essential oil to support overall health, wellbeing, and quality of life during the third trimester of pregnancy among otherwise healthy adult women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05000424
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Quality of Life
Currently open trials in the same condition.
- NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
- NCT07416448 — Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07412379 — Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer · recruiting
- NCT07380789 — Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07280416 — Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer · recruiting
Other Nutraceuticals Research Institute trials
Trials by the same sponsor.
- NCT07210229 — The Effectiveness of a Proprietary Ashwagandha Extract on Menopausal Symptoms: A Three-Arm Randomized, Double-Blinded, P · NA · not yet recruiting
- NCT06919328 — Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+ · NA · recruiting
- NCT06793891 — Effects of Ashwagandha Extract on Stress Levels · NA · recruiting
- NCT06894108 — The Effectiveness of a Proprietary of a Botanical Extract on Sleep Quality · NA · completed
- NCT06382688 — IV Administration of ChromaDex's Niagen® as Compared to NAD+ · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05000424 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nutraceuticals Research Institute
- Last refreshed: 2 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05000424.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing